HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat.

Abstract
β-adrenergic receptor activation promotes brown adipose tissue (BAT) β-oxidation and thermogenesis by burning fatty acids during uncoupling respiration. Oleoylethanolamide (OEA) can inhibit feeding and stimulate lipolysis by activating peroxisome proliferator-activating receptor-α (PPARα) in white adipose tissue (WAT). Here we explore whether PPARα activation potentiates the effect of β3-adrenergic stimulation on energy balance mediated by the respective agonists OEA and CL316243. The effect of this pharmacological association on feeding, thermogenesis, β-oxidation, and lipid and cholesterol metabolism in epididymal (e)WAT was monitored. CL316243 (1 mg/kg) and OEA (5 mg/kg) co-administration over 6 days enhanced the reduction of both food intake and body weight gain, increased the energy expenditure and reduced the respiratory quotient (VCO2/VO2). This negative energy balance agreed with decreased fat mass and increased BAT weight and temperature, as well as with lowered plasma levels of triglycerides, cholesterol, nonessential fatty acids (NEFAs), and the adipokines leptin and TNF-α. Regarding eWAT, CL316243 and OEA treatment elevated levels of the thermogenic factors PPARα and UCP1, reduced p38-MAPK phosphorylation, and promoted brown-like features in the white adipocytes: the mitochondrial (Cox4i1, Cox4i2) and BAT (Fgf21, Prdm16) genes were overexpressed in eWAT. The enhancement of the fatty-acid β-oxidation factors Cpt1b and Acox1 in eWAT was accompanied by an upregulation of de novo lipogenesis and reduced expression of the unsaturated-fatty-acid-synthesis enzyme gene, Scd1. We propose that the combination of β-adrenergic and PPARα receptor agonists promotes therapeutic adipocyte remodelling in eWAT, and therefore has a potential clinical utility in the treatment of obesity.
AuthorsJuan Suárez, Patricia Rivera, Sergio Arrabal, Ana Crespillo, Antonia Serrano, Elena Baixeras, Francisco J Pavón, Manuel Cifuentes, Rubén Nogueiras, Joan Ballesteros, Carlos Dieguez, Fernando Rodríguez de Fonseca
JournalDisease models & mechanisms (Dis Model Mech) Vol. 7 Issue 1 Pg. 129-41 (Jan 2014) ISSN: 1754-8411 [Electronic] England
PMID24159189 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adipokines
  • Adrenergic beta-3 Receptor Agonists
  • Dioxoles
  • Endocannabinoids
  • Lipids
  • Oleic Acids
  • PPAR alpha
  • Receptors, Adrenergic, beta
  • disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate
  • oleoylethanolamide
  • Cholesterol
  • Oxygen
Topics
  • Adipocytes, Brown (physiology)
  • Adipocytes, White (physiology)
  • Adipokines (metabolism)
  • Adrenergic beta-3 Receptor Agonists (chemistry)
  • Animals
  • Body Composition
  • Body Weight
  • Cholesterol (metabolism)
  • Dioxoles (chemistry)
  • Eating
  • Endocannabinoids
  • Epididymis (metabolism)
  • Homeostasis
  • Lipids (chemistry)
  • Liver (metabolism)
  • Male
  • Mitochondria (metabolism)
  • Obesity (therapy)
  • Oleic Acids (chemistry)
  • Oxygen (chemistry)
  • PPAR alpha (metabolism)
  • Phenotype
  • Phosphorylation
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, beta (metabolism)
  • Temperature
  • Thermogenesis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: